Before they can be marketed through the network of authorised professionals, veterinary medicinal products are subject to a Marketing Authorisation (MA), as are human medicinal products.
These authorisations are issued by the health authorities after submission and review of approved files. The MAs are valid for several years and must be renewed at the end of this period.
LAPROVET is fully committed to this ethical and quality approach by developing its portfolio of MAs throughout the world.
In Sub-Saharan Africa, LAPROVET has been involved with the West African Economic and Monetary Union (UEMOA), which includes Benin, Burkina Faso, Côte d’Ivoire, Togo, Guinea-Bissau, Mali, Senegal and Niger, since the implementation of the Community Regulations governing veterinary drugs in 2010. The company now has 36 Community Marketing Authorisations and is therefore to date the veterinary company with the largest number of Marketing Authorisations in the area.
The MA remains to this day one of the best protection against fraudulent products since it guarantees that the veterinary drug meets the quality, safety and efficacy standards in force. Combined with active import control, it ensures the availability of an approved therapeutic arsenal to improve animal health and thus help farmers to develop their business. On a larger scale, it is an important challenge for public health.